Skip to main content

Daniel E. Hyer, Phd

Director of Clinical Physics, MR-Linac Technical Director Associate Professor of Radiation Oncology
University of Lowa, USA
Daniel E. Hyer, Phd
  • Daniel E. Hyer, Phd

    Dr. Hyer earned his PhD in Medical Physics from the University of Florida in 2010. Upon graduation, he moved to the University of Iowa, where he currently works as an Associate Professor and the Director of Clinical Physics. He is board certified by the American Board of Radiology in Therapeutic Physics and his research interests  include MRI-guided radiotherapy and proton beam therapy. On the latter topic, he currently holds a National Cancer Institute grant for the development of a proton collimator.  Clinically, Dr. Hyer is the technical director of the Unity program at the University of Iowa and has been involved with the project since 2017. 

     

    Read more

William Hall, MD

Associate Professsor, Radiation Oncology and Surgery
Froedtert
Medical College of Wisconsin, USA
William Hall, MD
  • William Hall, MD

    I am a board-certified radiation oncologist with a passion for research in gastrointestinal malignancies and radiological sciences. I completed my undergraduate studies in Biomedical Engineering with a focus in Biocomputing at Marquette University. I attended medical school at Loyola University in Chicago and completed residency at Emory University in Atlanta, Georgia. Thus far, in the early portion of my career, I have devoted my efforts to understanding the integration of advanced imaging modalities, including MRI, into radiation treatment planning. My specific interests relate to radiation therapy technological advances and MRI incorporation into radiation planning, and the optimal radiation therapy dosing strategy. My future research goals are focused on developing and improving our ability to identify patients that may not require surgery for rectal cancer. In addition, I hope to develop MRI strategies that would use novel and unique MRI sequences to enable precise delineation of the most malignant portions of a tumor. I see the next decade of research to be an exciting and transformative time in the management of several different malignancies. 

    Read more

Detected timezone